Scigenix is pleased to report that according to the Dayton Daily News, Diatherix, Inc. has recently leased space at Kettering Medical Center to initiate a partnership in the testing of infectious diseases.

According to the article, Kettering Medical Center, expects to save almost $225,000 per year in MRSA related uses alone.  Quoting directly from the article, "Diatherix's licensed method, called Target-Enriched Multiplex Polymerase Chain Reaction (TEM-PCR), can identify up to 25 pathogens in a single specimen in a single test..."

As the chemistry provider for Diatherix, Scigenix is proud to be associated with this cost saving partnership between Diatherix and Kettering Medical Center.